Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (81-90 of 418) with videos related to

Pageof 42
Sort By:
Critical Reviews in Oncology/Hematology|May 22, 2019
State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enoughMelissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Clinical Lung Cancer|November 24, 2016
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysisAnna La Salvia, Antonio Rossi, Domenico Galetta, et al.
Anti-Cancer Drugs|November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumorsMassimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.
Critical Reviews in Oncology/Hematology|February 21, 2018
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patientsChiara Baratelli, Clizia Zichi, Massimo Di Maio, et al.
Histology and Histopathology|June 1, 2026
Mixed/combined pulmonary non-small cell carcinoma and carcinoid: State-of-the-Art review of clinical, histological, and molecular features with therapeutic implicationsPaola Parente, Luisella Righi, Marco Donatello Delcuratolo, et al.
Journal of Cancer Policy|January 29, 2026
Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014Celeste Cagnazzo, Evaristo Maiello, Roberto Labianca, et al.
European Urology|October 1, 2015
Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysisMarcello Tucci, Valentina Bertaglia, Francesca Vignani, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implicationsChiara Pisano, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Plos One|July 2, 2014
Clinical and organizational issues in the management of surviving breast and colorectal cancer patients: attitudes and feelings of medical oncologistsGianmauro Numico, Carmine Pinto, Stefania Gori, et al.
Pageof 42

Showing results (81-90 of 418) with videos related to

Sort By:
Pageof 42
Critical Reviews in Oncology/Hematology|May 22, 2019
State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enoughMelissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, et al.
Lung Cancer (Amsterdam, Netherlands)|October 31, 2009
Methodological aspects of lung cancer clinical trials in the era of targeted agentsMassimo Di Maio, Ciro Gallo, Ermelinda De Maio, et al.
Clinical Lung Cancer|November 24, 2016
Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysisAnna La Salvia, Antonio Rossi, Domenico Galetta, et al.
Anti-Cancer Drugs|November 21, 2012
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumorsMassimo Di Maio, Emilio Bria, Giuseppe L Banna, et al.
Critical Reviews in Oncology/Hematology|February 21, 2018
A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patientsChiara Baratelli, Clizia Zichi, Massimo Di Maio, et al.
Histology and Histopathology|June 1, 2026
Mixed/combined pulmonary non-small cell carcinoma and carcinoid: State-of-the-Art review of clinical, histological, and molecular features with therapeutic implicationsPaola Parente, Luisella Righi, Marco Donatello Delcuratolo, et al.
Journal of Cancer Policy|January 29, 2026
Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014Celeste Cagnazzo, Evaristo Maiello, Roberto Labianca, et al.
European Urology|October 1, 2015
Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysisMarcello Tucci, Valentina Bertaglia, Francesca Vignani, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implicationsChiara Pisano, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Plos One|July 2, 2014
Clinical and organizational issues in the management of surviving breast and colorectal cancer patients: attitudes and feelings of medical oncologistsGianmauro Numico, Carmine Pinto, Stefania Gori, et al.
Pageof 42